Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omics phenotyping in heart failure: the next frontier

30 Mar 2020

Abstract excerpt

This state-of-the-art review aims to provide an up-to-date look at breakthrough omic technologies that are helping to unravel heart failure (HF) disease mechanisms and heterogeneity. Genomics, transcriptomics, proteomics, and metabolomics in HF are reviewed in depth. In addition, there is a thorough, expert discussion regarding the value of omics in identifying novel disease pathways, advancing understanding of...

Topics

Join the communities discussing this publication.

Cardiovascular Function and Risk Factors
Heart Failure Treatment and Management
Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32337540
DOI: 10.1093/eurheartj/ehaa270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omics phenotyping in heart failure: the next frontierPMID 32337540Read ↗

404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure ResearchSemantic proximity Read ↗

Drug Discovery and Development for Heart Failure Using Multi-Omics ApproachesSemantic proximity Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

An 'Omics' Perspective on Cardiomyopathies and Heart Failure.Semantic proximity Read ↗

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicineSemantic proximity Read ↗

Metabolic Heterogeneity Across Heart Failure Subtypes Defined by Integrative Multi-Omics Analysis.Semantic proximity Read ↗

Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart FailureSemantic proximity Read ↗

The omics of channelopathies and cardiomyopathies: what we know and how they are usefulSemantic proximity Read ↗

Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and PerspectivesSemantic proximity Read ↗

Metabolomic profile for understanding heart failure classificationsSemantic proximity Read ↗

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.Semantic proximity Read ↗

Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.